Literature DB >> 20884750

Possible mechanisms for delayed migration of the closed cell--designed enterprise stent when used in the adjunctive treatment of a basilar artery aneurysm.

B Gao, A M Malek.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20884750      PMCID： PMC7964020          DOI： 10.3174/ajnr.A2258

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  5 in total

1.  Stent conformity in curved vascular models with simulated aneurysm necks using flat-panel CT: an in vitro study.

Authors:  N Ebrahimi; B Claus; C-Y Lee; A Biondi; G Benndorf
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

2.  Another delayed migration of an enterprise stent.

Authors:  G J Rodriguez; A Maud; R A Taylor
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

3.  Delayed migration of a self-expanding intracranial microstent.

Authors:  M E Kelly; R D Turner; S I Moskowitz; V Gonugunta; M S Hussain; D Fiorella
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-21       Impact factor: 3.825

4.  Increased cell opening and prolapse of struts of a neuroform stent in curved vasculature: value of angiographic computed tomography: technical case report.

Authors:  Goetz Benndorf; Benjamin Claus; Charles M Strother; Lee Chang; Richard P Klucznik
Journal:  Neurosurgery       Date:  2006-04       Impact factor: 4.654

5.  Spontaneous delayed proximal migration of enterprise stent after staged treatment of wide-necked basilar aneurysm: technical case report.

Authors:  Sean D Lavine; Philip M Meyers; E Sander Connolly; Robert S Solomon
Journal:  Neurosurgery       Date:  2009-05       Impact factor: 4.654
  5 in total
  8 in total

1.  Comparison between Solitaire™ AB and Enterprise stent-assisted coiling for intracranial aneurysms.

Authors:  Hua-Wei Ye; Ya-Qi Liu; Qiu-Jing Wang; Tao Zheng; Xu-Bo Cui; Yu-Yuan Gao; Ling-Feng Lai; Xin Zhang; Xi-Feng Li; Shi-Xing Su; Xu-Ying He; Chuan-Zhi Duan
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

2.  Stent-assisted coiling of intracranial bifurcation aneurysms leads to immediate and delayed intracranial vascular angle remodeling.

Authors:  B Gao; M I Baharoglu; A D Cohen; A M Malek
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

3.  First Experiences with the New Enterprise2® Stent.

Authors:  C Herweh; S Nagel; J Pfaff; C Ulfert; M Wolf; M Bendszus; M Möhlenbruch
Journal:  Clin Neuroradiol       Date:  2016-09-27       Impact factor: 3.649

4.  Modified protection using far proximal portion of self-expandable closed-cell stents for embolization of wide-necked intracranial aneurysms.

Authors:  Young Dae Cho; Hyun-Seung Kang; Jeong Eun Kim; Won-Sang Cho; Hyon-Jo Kwon; Hyeon-Song Koh; Moon Hee Han
Journal:  Neuroradiology       Date:  2014-07-20       Impact factor: 2.804

5.  Spontaneous delayed migration/shortening of the pipeline embolization device: report of 5 cases.

Authors:  N Chalouhi; S I Tjoumakaris; L F Gonzalez; D Hasan; P J Pema; G Gould; R H Rosenwasser; P M Jabbour
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

6.  The LVIS Jr. microstent to assist coil embolization of wide-neck intracranial aneurysms: clinical study to assess safety and efficacy.

Authors:  M Möhlenbruch; C Herweh; L Behrens; L Jestaedt; H Amiri; P A Ringleb; M Bendszus; M Pham
Journal:  Neuroradiology       Date:  2014-03-06       Impact factor: 2.804

7.  Hemodynamic and Geometric Risk Factors for In-Stent Restenosis in Patients with Intracranial Atherosclerotic Stenosis.

Authors:  Xiaowen Song; Hancheng Qiu; Shuo Wang; Yong Cao; Jizong Zhao
Journal:  Oxid Med Cell Longev       Date:  2022-07-27       Impact factor: 7.310

8.  "Shelf" Technique Using a Novel Braided Self-Expandable Stent for the Treatment of Wide-Necked Bifurcation Aneurysms.

Authors:  Volker Maus; Werner Weber; Sebastian Fischer
Journal:  Clin Neuroradiol       Date:  2021-07-20       Impact factor: 3.649
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.